Navigation Links
Verum.de Chosen to Provide Clinical Research Services for Oncology Center in Romania
Date:1/23/2013

SAN DIEGO, Jan. 23, 2013 /PRNewswire/ -- Verum.de, a full-clinical service, German-based contract research organization (CRO) with a new office in Carlsbad, Calif., has entered into an agreement with the Center for Oncologic Diagnosis and Treatment (Oncocard) in Romania to be its preferred provider of clinical trial services. The center, developed with the first private investment funding in oncology in Romania, is brand new and features state-of-the-art services and equipment. The center selected Verum.de as their CRO of choice so they could assist with running clinical trials and offer patients all possible treatment options.  

(Logo:  http://photos.prnewswire.com/prnh/20120807/LA53176LOGO)

"The esteemed medical professionals involved with the center provide patients a sophisticated level of treatment and services that are rare for the area," stated Verum's local Romanian Medical Director Laurentiu Nedelcu , a doctor and pharmacologist who has supervised Verum trials since 1996. "Verum is known for its regional expertise, and we're pleased to be the CRO the center has chosen to work with."

The Oncology Center, which opened in June, 2012, is a 86,112 sq. feet clinic offering full spectrum oncologic chemotherapy, radiotherapy, treatment of hematological malignancies and surgical services to patients in addition to serving as an investigative center for research. The Oncology Center's medical staff is highly qualified and many of the Oncology Center's staff doctors have experience working with Verum. To date, more than 1,700 patients have been treated at the facility and more than 3,800 investigations have been performed.

"The center was opened to offer a higher level of care to cancer patients, with the best services and equipment modern medicine has available," explained the center's Medical Director, Dr. Mihai Ciochinaru . "We trust working with a CRO such as Verum, which runs trials in an efficient, highly ethical manner and understands the region."

Verum provides clinical trial services with Western standards in Central and Eastern European countries (CEE) and former Soviet bloc countries. Verum recently opened a U.S. office in Carlsbad to assist U.S. clients with international trials, and the new office is headed by Kristi Clark , an industry veteran with more than 20 years of pharma and biotech experience in both large and mid-size CROs.

About Verum.de
German-based Verum.de was founded by Christian Sacher and Jutta Minkner (CFO), two industry pioneers with more than 25 years experience running clinical trials in CEE and former Soviet bloc countries. Verum has more than 100 office based employees operating out of eight locations, including its Munich headquarters, and the company offers therapeutic specialties in cardiovascular, neurology, psychiatry, CNS, oncology and pain, among others. Verum started operations in 1992 in CEE countries based on Western ideals and ethical standards. Verum has substantial contacts with local authorities, and is known in CEE for the flexible and responsive services it provides. More information can be found at http://www.verum.de

CONTACT:
Rachel Hutman
Clearpoint Agency, for Verum.de
rachel@clearpointagency.com
760-230-2424


'/>"/>
SOURCE Verum.de
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Providence Health & Services Selects Conflict of Interest Management System
2. Jet-lagged fruit flies provide clues for body clock synchronisation
3. Sustainable Valley Technology Group Provides Technology Innovation Grant To Help Researchers & Start-Ups With Funding, Business Support, Equipment & Facilities
4. Bottom-up approach provides first characterization of pyroelectric nanomaterials
5. Mobility and Big Data Analytics Provider NuWare Announces the Appointment of Rohit Shyam as Chief Strategy & Marketing Officer
6. Stem Cell and Telomere Support Provided by Stem Cell 100 from Life Code
7. RAPS, Eucomed Partner to Provide Online Training to Regulatory Professionals Throughout Europe
8. Galileo Analytics Announces Agreement to Provide Analytic Component of ASCOs CancerLinQ Prototype
9. Array BioPharma Provides Updates On Clinical Data At The 2012 American Society Of Hematology Meeting
10. Bayer CropScience Provides a Glimpse of SeedGrowthâ„¢ Innovation
11. Organovo Reports Q3 2012 Financial Results, Provides Business Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... 2016  Wellcentive today announced it has been ... -based community care organization (CCO) with more ... quality reporting and care management solutions and services. ... of quality managers, analysts and care managers while ... serving FamilyCare members. Oregon ...
(Date:2/11/2016)... 2016   BioInformant announces the February 2016 ... Products, Opportunities, Tools, and Technologies – Market Size, Segments, ... The first and only ... industry, BioInformant has more than a decade of historical ... by stem cell type. This powerful 175 page global ...
(Date:2/10/2016)... , Febr. 10, 2016 /PRNewswire/ - BioAmber Inc. (NYSE: ... to announce that Mitsui & Co. Ltd., its partner ... acid plant, is investing an additional CDN$25 million in ... its stake from 30% to 40%.  Mitsui will also ... acid produced in Sarnia , providing ...
(Date:2/10/2016)... -- ASAE is introducing a hybrid membership model which ... option of joining or renewing through an organizational purchasing ... size, every employee in any size association or AMC ... available member benefits.   John H. Graham, ... will allow organizations of any size and their employees ...
Breaking Biology Technology:
(Date:2/2/2016)... 2, 2016 This BCC Research report ... by reviewing the recent advances in high throughput ... the field forward. Includes forecast through 2019. ... challenges and opportunities that exist in the bioinformatic ... developers, as well as IT and bioinformatics service ...
(Date:2/2/2016)... , Feb. 2, 2016  Based on its ... & Sullivan recognizes US-based Intelligent Retinal Imaging Systems ... Sullivan Award for New Product Innovation. IRIS, a ... North America , is poised to ... growing diabetic retinopathy market. The IRIS technology presents ...
(Date:1/28/2016)... Jan. 28, 2016 Synaptics (NASDAQ: SYNA ), a ... its second quarter ended December 31, 2015. ... of fiscal 2016 increased 2 percent compared to the comparable quarter ... of fiscal 2016 was $35.0 million, or $0.93 per diluted share. ... income for the first quarter of fiscal 2016 grew 9 percent ...
Breaking Biology News(10 mins):